JP2001039953A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001039953A5 JP2001039953A5 JP1999214280A JP21428099A JP2001039953A5 JP 2001039953 A5 JP2001039953 A5 JP 2001039953A5 JP 1999214280 A JP1999214280 A JP 1999214280A JP 21428099 A JP21428099 A JP 21428099A JP 2001039953 A5 JP2001039953 A5 JP 2001039953A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- antibody
- antigen
- compound
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- 150000001875 compounds Chemical class 0.000 description 16
- 239000000427 antigen Substances 0.000 description 15
- 102000036639 antigens Human genes 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 15
- 239000012634 fragment Substances 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- -1 4,6-dimethoxypyrimidin-2-yloxy Chemical group 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- USSIUIGPBLPCDF-KEBDBYFISA-N pyriminobac-methyl Chemical group CO\N=C(/C)C1=CC=CC(OC=2N=C(OC)C=C(OC)N=2)=C1C(=O)OC USSIUIGPBLPCDF-KEBDBYFISA-N 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 0 *c1cccc(*c2nc(*)cc(*)n2)c1* Chemical compound *c1cccc(*c2nc(*)cc(*)n2)c1* 0.000 description 2
- LEQMMCVQBXAGON-UHFFFAOYSA-N CCOC(=O)C(C)CCCOC1=NC(=NC(=C1)C)SC Chemical compound CCOC(=O)C(C)CCCOC1=NC(=NC(=C1)C)SC LEQMMCVQBXAGON-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- OCOHPSHRDKBGOZ-UHFFFAOYSA-N 6-methyl-2-methylsulfanyl-1h-pyrimidin-4-one Chemical compound CSC1=NC(=O)C=C(C)N1 OCOHPSHRDKBGOZ-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DXBULVYHTICWKT-UHFFFAOYSA-N ethyl 6-bromohexanoate Chemical compound CCOC(=O)CCCCCBr DXBULVYHTICWKT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11214280A JP2001039953A (ja) | 1999-07-28 | 1999-07-28 | ピリミノバックメチルのハプテン化合物、抗体及び測定方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11214280A JP2001039953A (ja) | 1999-07-28 | 1999-07-28 | ピリミノバックメチルのハプテン化合物、抗体及び測定方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001039953A JP2001039953A (ja) | 2001-02-13 |
| JP2001039953A5 true JP2001039953A5 (enExample) | 2006-09-14 |
Family
ID=16653128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11214280A Withdrawn JP2001039953A (ja) | 1999-07-28 | 1999-07-28 | ピリミノバックメチルのハプテン化合物、抗体及び測定方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001039953A (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105272925A (zh) * | 2015-11-25 | 2016-01-27 | 常州大学 | 一种水稻田除草剂嘧草醚的制备方法 |
| CN110839648A (zh) * | 2018-08-21 | 2020-02-28 | 燕化永乐（乐亭）生物科技有限公司 | 一种除草组合物 |
-
1999
- 1999-07-28 JP JP11214280A patent/JP2001039953A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS59101486A (ja) | トマイマイシン中間体化合物とその製造法 | |
| JPH0138798B2 (enExample) | ||
| KR20010070987A (ko) | 퀴놀린 유도체의 제조방법 및 중간체 | |
| JP2001039953A5 (enExample) | ||
| SK280164B6 (sk) | Spôsob výroby n-(n-alkánsulfonyl)-o-[4-(4-piperidi | |
| JP2000191624A5 (enExample) | ||
| JP2001272401A (ja) | フタル酸エステル類のハプテン化合物、抗体及び測定方法 | |
| TW200844100A (en) | Regio-selective Ullmann synthesis of 4-bromo-3-methyl-5-propoxy-thiophene-2-carboxylic acid | |
| CA2084314C (en) | Starting compounds for the production of 10beta-h steroids and process for producing such starting compounds | |
| JP2001039959A5 (enExample) | ||
| JP2000219695A5 (enExample) | ||
| JP3026040B2 (ja) | ｈＣＧ関連７糖性ハプテン | |
| JPH11269157A5 (enExample) | ||
| JPH1132762A5 (enExample) | ||
| CN120025275A (zh) | 卤素代酚丁类半抗原化合物及其制备方法和用途 | |
| JPH11152284A (ja) | 環状フェノール硫化物カルボン酸エステルの製造法 | |
| JPS59148799A (ja) | １６β−メチルステロイド方法 | |
| JPS5843399B2 (ja) | プロゲステロンカラユウドウサレルシンキナハプテンノ セイゾウホウ オヨビ ソレラノ コウゲンノチヨウセイヘノシヨウ | |
| JP2001158774A (ja) | ６−トリフルオロメチルニコチン酸類の製造方法 | |
| JP5207233B2 (ja) | 糖付加インドール化合物の製造方法 | |
| JPH0261932B2 (enExample) | ||
| JP2000281645A (ja) | クロルフェナピルのハプテン化合物、抗体及び測定方法 | |
| JPH06273417A (ja) | メバロン酸に対する抗体、および該抗体を用いるメバロン酸の定量法 | |
| CN120025276A (zh) | 酚丁类半抗原化合物及其制备方法、完全抗原、应用 | |
| JP2001039953A (ja) | ピリミノバックメチルのハプテン化合物、抗体及び測定方法 |